Indications |
Oral Mild to moderate pain Adult: 30-60 mg every 4 hr. Max: 240 mg daily. Child: 1-12 yr: 500 mcg/kg 4-6 times daily. Renal impairment: Dose adjustment may be needed. Hepatic impairment: Dose adjustment may be needed. Oral Cough suppressant Adult: 15-30 mg 3-4 times daily. Max: 240 mg/day. Child: 1-5 yr: 3 mg; 5-12 yr: 7.5-15 mg. Doses to be taken 3-4 times daily. Renal impairment: Dose adjustment may be needed. Hepatic impairment: Dose adjustment may be needed. Oral Acute diarrhoea Adult: 30 mg 3-4 times daily. Renal impairment: Dose adjustment may be needed. Hepatic impairment: Dose adjustment may be needed. Parenteral Mild to moderate pain Adult: IV/IM/SC: 30-60 mg every 4 hr. Max: 240 mg/day. Child: IM/SC: 1-12 yr: 500 mcg/kg 4-6 times daily. Renal impairment: Dose adjustment may be needed. Hepatic impairment: Dose adjustment may be needed. |
Contraindications |
Respiratory depression, obstructive airway disease, asthma. Acute alcoholism, convulsive disorders, head injuries, comatose patients, raised intracranial pressure. Pregnancy (prolonged use or high doses at term). |
Warnings / Precautions |
Hypothyroidism, adrenocortical insufficiency; asthma, impaired hepatic or renal function, prostatic hyperplasia, hypotension, shock, inflammatory or obstructive bowel disorders, myasthenia gravis. Infants, neonates; Reduce dose in elderly or debilitated patients. May impair ability to drive or operate machinery. Lactation. |
Adverse Reactions |
Dependence, withdrawal symptoms; nausea, vomiting, constipation; drowsiness, confusion; difficulty in micturition, ureteric or biliary spasms, urinary retention; dry mouth, dizziness, sweating, facial flushing, headache, vertigo, bradycardia, tachycardia, palpitations, orthostatic hypotension, hypothermia, restlessness, mood changes, decreased libido or potency, hallucination, miosis; raised intracranial pressure, muscle rigidity. Potentially Fatal: Respiratory depression and hypotension, with circulatory failure and deepening coma (larger doses). Convulsions (especially in children and infants). Rhabdomyolysis. |
Overdose Reactions |
CNS depression ranging from stupor to coma, respiratory depression which may progress to Cheyne-Stokes respiration, cyanosis, miosis, hypothermia, flaccid skeletal muscles, bradycardia and hypotension. Maintain an adequate, patent airway, using assisted or controlled respiration and oxygen as needed. Supportive and symptomatic treatment Parenteral naloxone may be given after weighing benefits versus risk of acute withdrawal syndrome in physically dependent patients. If respiratory depression is associated with muscular rigidity, admin of a neuromuscular blocking agent may help assist or control respiration. Gastric lavage may be effective many hr after drug ingestion since pylorospasm produced result in retention of the drug in the stomach for an extended period of time. |
Drug Interactions |
Enhanced depressant effects with alcohol, anaesthetics, anxiolytics, hypnotics, TCAs, antipsychotics. Possible CNS depression or excitation with MAOIs. May alter effects of other compounds e.g. cyclizine, mexiletine, cisapride, metoclopramide and domperidone. See Below for More codeine Drug Interactions |
Mechanism of Actions |
Codeine provides relief by blocking the ascending pain pathways by binding to opiate receptors found in the CNS. It also helps suppress cough by direct action in the medulla. Onset: Oral: 0.5-1 hr. IM: 10-30 min. Duration: 4-6 hr. Absorption: Oral and rectal: Adequate. Distribution: Crosses placenta and enters breast milk. Metabolism: Hepatic by O- and N-demethylation to morphine (active), norcodeine and other metabolites including normorphine and hydrocodone. Excretion: In the urine, mainly as conjugates with glucuronic acid. Plasma half-life: about 3-4 hr. |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store at 15-30°C. Parenteral: Store at 15-30°C. |
ATC Classification |
R05DA04 - codeine ; Belongs to the class of opium alkaloids and derivatives. Used as cough suppressant. |
Storage |
Oral: Store at 15-30°C. Parenteral: Store at 15-30°C. |
Available As |
|
Codeine
Post Review about Codeine Click here to cancel reply.
Codeine Containing Brands
Codeine is used in following diseases
Drug - Drug Interactions of Codeine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.